Lilach Payorski - 27 Aug 2026 Form 4 Insider Report for KAMADA LTD (KMDA)

Reporting relationship: Director
Issuer ticker: KMDA
Reported as of: 27 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Sep 2026, 15:22:21 UTC
Prior SEC filing: 06 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Lilach Payorski

Key filing fact

Lilach Payorski filed Form 4 for KAMADA LTD (KMDA) on 24 Sep 2026.

Key facts

This page summarizes Lilach Payorski's Form 4 filing for KAMADA LTD (KMDA).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 24 Sep 2026, 15:22.

Change

Previous filing in this sequence was filed on 06 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002007989 Primary reporting owner

Payorski Lilach

Relationship: Director
Address: 2 HOLTZMAN ST., REHOVOT, ISRAEL
Signature: /s/ Lilach Payorski
Signature date: 24 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KMDA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +30,000
Change %
Price: $0.000000^*
Shares after: 30,000
Date: 27 Aug 2026
Ownership: Held by trustee
Underlying class: Ordinary Shares
Underlying amount: 30,000
Exercise price: $5.99
Footnotes: F1, F2, F3, F4

KMDA transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +30,000
Change %
Price: $0.000000^*
Shares after: 30,000
Date: 27 Aug 2026
Ownership: Held by trustee
Underlying class: Ordinary Shares
Underlying amount: 30,000
Exercise price: $7.38
Footnotes: F1, F2, F3, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The exercise prices of all options reported in this Form 4 are denominated in New Israeli Shekels (NIS). For presentation purposes, all exercise prices presented in this Form 4, including those referenced in the footnotes, are presented in U.S. dollars (USD) based on the NIS/USD exchange rate published by the Bank of Israel as of September 22, 2026.

Footnote F2

The options will vest over a period of four years in four equal installments, such that 25% of the options will vest on each anniversary of the grant date. The options will be exercisable for a period of 10 years following the date of grant, and all unexercised options will expire immediately thereafter.

Footnote F3

Held by trustee under the Company's 2011 Share Award Plan.

Footnote F4

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $6.15. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.

Footnote F5

This option was previously reported as covering 30,000 ordinary shares at an exercise price of $7.55. The exercise price has been adjusted in connection with a special cash dividend distribution declared by the Company's board of directors on August 17, 2026 with a record date for the special cash dividend of August 27, 2026.